Physician profile
Aaron P Tracy
NPI 1700230984
$843.46
in general payments reported to CMS, 2019-2025
13 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $197 · 2024: $234 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $135.78 | 2024-2025 | Zynrelef |
| Kowa Pharmaceuticals America, INC. | $118.98 | 2023 | Seglentis |
| Nevro Corp. | $98.35 | 2024 | Senza |
| Vertex Pharmaceuticals Incorporated | $97.63 | 2024-2025 | |
| Radius Health, INC. | $92.78 | 2025 | Tymlos |
| Depuy Synthes Sales INC. | $92.12 | 2023-2025 | Orthovisc, Monovisc |
| Medinc of Texas | $53.00 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $46.97 | 2023-2025 | Zilretta, Iovera |
| Axogen | $35.38 | 2025 | |
| Kci USA, INC. | $21.47 | 2023 | Prevena |
| Solventum Corporation | $19.25 | 2024 | Activ.A.C., Prevena |
| Kerecis Limited | $16.59 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Vericel Corporation | $15.16 | 2024 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Tracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.